Quantitative SUMO proteomics reveals the modulation of several PML nuclear body associated proteins and an anti-senescence function of UBC9.

Several regulators of SUMOylation have been previously linked to senescence but most targets of this modification in senescent cells remain unidentified. Using a two-step purification of a modified SUMO3, we profiled the SUMO proteome of senescent cells in a site-specific manner. We identified 25 SUMO sites on 23 proteins that ...
were significantly regulated during senescence. Of note, most of these proteins were PML nuclear body (PML-NB) associated, which correlates with the increased number and size of PML-NBs observed in senescent cells. Interestingly, the sole SUMO E2 enzyme, UBC9, was more SUMOylated during senescence on its Lys-49. Functional studies of a UBC9 mutant at Lys-49 showed a decreased association to PML-NBs and the loss of UBC9's ability to delay senescence. We thus propose both pro- and anti-senescence functions of protein SUMOylation.
Mesh Terms:
Cell Nucleus, Cellular Senescence, Humans, Nuclear Proteins, Promyelocytic Leukemia Protein, Protein Conformation, Proteome, Small Ubiquitin-Related Modifier Proteins, Sumoylation, Tumor Cells, Cultured, Ubiquitin-Conjugating Enzymes
Sci Rep
Date: Dec. 17, 2017
Download Curated Data For This Publication
221414
Switch View:
  • Interactions 3